As both HRT and semaglutide rise in popularity, theres an increased chance that women may take them together to combat menopause, diabetes, obesity, and other health issues
There is no direct evidence that IGF-1 peptides cause cancer, but because IGF-1 promotes cellular proliferation , individuals with a history of cancer or pre-cancerous conditions should avoid use unless under medical supervision
Because BPC-157s target receptor has not been conclusively identified, researchers frequently describe its activity using hypothesis-driven language rather than confirmed mechanistic claims
The results of Medical Weight Loss can be nothing short of life-changing
Still, canceling can be a process
Clinical data shows patients using semaglutide lose approximately 15% of body weight over 68 weeks compared to 2-3% with lifestyle changes alone